Why High-Quality Raw Materials Are Vital | Producing Therapeutic Cardiomyocytes from iPSC Stem Cells

In this webinar, experts from Albumedix and Heartseed show how they were able to ease challenges enroute to commercialization and bring a potential cardiomyocyte therapy to clinical trials. 

  1. The journey of Heartseed’s investigative cardiomyocyte therapy for heart failure patients, now in Phase I/II clinical trials
  2. The value albumin delivers across advanced therapy applications
  3. How implementing Recombumin® into a manufacturing process can help improve production and support stability
  4. The key benefits of using chemically defined raw materials
  5. And more…

Please Complete the Form

Complete Form to Register